These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26461024)

  • 1. Erratum to: Wattson DA, Chen M-H, Moul JW, et al. The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: Implications for treatment selection. Int J Radiat Oncol Biol Phys 2012;82:e773-e779.
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):730. PubMed ID: 26461024
    [No Abstract]   [Full Text] [Related]  

  • 2. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 3. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
    Oton CA; Oton F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350).
    Oton CA
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937
    [No Abstract]   [Full Text] [Related]  

  • 5. Erratum to: Sanders JW, Venkatesan AM, Levitt CA, et al. Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys 2021;109(2):614-625.
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):238. PubMed ID: 35427557
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to "Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size" (Int J Radiat Oncol Biol Phys 2011;79:1318-1322).
    Tunio M; Hashmi A
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1195-6; author reply 1196. PubMed ID: 22036166
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to "Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy" (Int J Radiat Oncol Biol Phys 2009, in press).
    Froehner M; Koch R; Litz RJ; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1274. PubMed ID: 20206022
    [No Abstract]   [Full Text] [Related]  

  • 11. In regard to Thomadsen et al.: Analysis of treatment delivery errors in brachytherapy using formal risk analysis techniques (Int J Radiat Oncol Biol Phys 2003;57:1492-1508).
    Patton GA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):915; author reply 915-6. PubMed ID: 15183499
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
    Barthelemy-Brichant N
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
    [No Abstract]   [Full Text] [Related]  

  • 13. Erratum to: Fung CY, Chen E, Vapiwala N, et al. The American Society for Radiation Oncology 2017 Radiation Oncologist Workforce Study. Int J Radiat Oncol Biol Phys 2019;103:547-556.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967235
    [No Abstract]   [Full Text] [Related]  

  • 14. In regards to Dickler et al.: Treatment volume and dose optimization of mammosite breast brachytherapy applicator (Int J Radiat Oncol Biol Phys 2004;59:469-474).
    Chopra S
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):630; author reply 630-1. PubMed ID: 15667988
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
    Rubenstein J
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):305; author reply 305-6. PubMed ID: 15629630
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum to: Polishchuk AL, Li R, Hill-Kayser C, et al. Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 2014;89:839-845.
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):729. PubMed ID: 26461022
    [No Abstract]   [Full Text] [Related]  

  • 17. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    Duggan L; Bucci J; Kron T
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Zhongjie Chen, Yinshan Fang, Si Zhang, et al. Haplodeletion of Follistatin-Like 1 Attenuates Radiation-Induced Pulmonary Fibrosis in Mice. Int J Radiat Oncol Biol Phys 2019;103:208-216.
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):890. PubMed ID: 32092348
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
    Moerland MA; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
    [No Abstract]   [Full Text] [Related]  

  • 20. In regard to Pisch et al: placement of 125I implants with the da Vinci robotic system after video-assisted thoracoscopic wedge resection: a feasibility study (INT J RADIAT ONCOL BIOL PHYS 2004;60:928-932).
    Colonias A; Parda DS
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1277-8; author reply 1278. PubMed ID: 15752912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.